Ideas. Action. Results.

The Role of Medicines in Health Care Delivery

Marisa Salemme / Blog June 27, 2016

Panelists agreed that a lack of transparency of claims and lab data, as well as long-term outcomes, had inhibited the movement to value-based payments.

Read More

Educational Series on Affordable Medicines: Value-Based Payments and Financing Breakthrough Treatments

Health / June 16, 2016 1:00 p.m. to 2:30 p.m. ET

The forum was the third and final event in BPC’s educational series to inform the national conversation on affordable medicines.

Read More

How Federal Policies Impact Innovation and Costs of Pharmaceutical Therapies

Marisa Salemme / Blog May 17, 2016

BPC continued its series on affordable medicines, examining the role of federal government policy on pharmaceutical innovation, market competition, and costs.

Read More

With Health Care in the Spotlight, Experts Discuss Affordability of Medicines

Marisa Salemme / Blog April 22, 2016

The money spent on prescription drugs as a share of total health care spending has risen in recent years, raising questions about drug prices, costs, and access.

Read More

Educational Series on Affordable Medicines: Impact of Federal Policy on Innovation, Competition, and Costs

Health / May 10, 2016 10:00 a.m. to 11:30 a.m. ET

The forum was the second in a series examining how private sector decisions and public sector policies impact the prices of drugs and their costs to the health care system.

Read More

Educational Series on Affordable Medicines: Pricing, Repricing, Rebates, and Patient Access

Health / April 13, 2016 10:00 a.m. to 11:30 a.m. ET

The forum is the first in a series examining how private sector decisions and public sector policies impact the prices of drugs and their costs to the health care system.

Read More